<DOC>
	<DOCNO>NCT00378352</DOCNO>
	<brief_summary>The purpose study evaluate whether erythropoietin help limit damage heart patient acute heart attack .</brief_summary>
	<brief_title>REVEAL : Reduction Infarct Expansion Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction</brief_title>
	<detailed_description>REVEAL randomize , double-blinded , placebo-controlled , parallel phase II clinical study evaluate effect erythropoietin administration infarct size , leave ventricular remodel circulate endothelial progenitor cell patient large myocardial infarction ( MI ) . The study conduct two phase : dose-escalation safety phase single dose efficacy phase . Eligible patient present hospital acute ST-elevation MI agree participate study randomly assign receive single infusion study medication consist either erythropoietin placebo . The size infarction dimension heart assess cardiac magnetic resonance imaging ( MRI ) within 2-6 day infusion study medication , approximately 3 month later .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ventricular Remodeling</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>INCLUSION CRITERIA : Age great 21 year Acute STelevation myocardial infarction Referral primary rescue angioplasty Revascularization procedure within 8 hour onset ischemic symptom TIMI ( Thrombolysis myocardial infarction ) flow grade 0 1 culprit coronary artery begin coronary angiography Successful revascularization infarctrelated artery EXCLUSION CRITERIA : Clinical indication erythropoietin STEMI ( STelevation myocardial infarction ) due occlusion branch vessel Any history prior MI , PCI ( Percutaneous coronary intervention ) , CABG ( Coronary artery bypass graft ) , cardiomyopathy , myocarditis , CHF ( congestive heart failure ) Hypersensitivity human albumin , mammalian cellderived product , erythropoietin Hematocrit great 42 % men great 40 % woman time study drug administration Uncontrolled hypertension time study drug administration Cardiogenic shock Need coronary surgical revascularization determine time index coronary catheterization History hypercoagulable disorder , thromboembolic event , venous thrombosis History stroke TIA ( transient ischemic attack ) History seizure Contraindication MRI Pregnancy nursing mother</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Acute Myocardial Infarction</keyword>
	<keyword>Left Ventricular Remodeling</keyword>
	<keyword>Cardiac Magnetic Resonance Imaging</keyword>
	<keyword>Endothelial Progenitor Cells</keyword>
	<keyword>Infarct Size</keyword>
</DOC>